BioMarin Pharmaceutical
BMRN
$92.68
Share price
1.10%
Change (1 day)
14.19%
Change (1 year)
Categories
Operating Margin for BioMarin Pharmaceutical (BMRN)
Operating Margin as of March 2023 (TTM): 5.00%
According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 5.00%. At the end of 2021 the company had an Operating Margin of -4.08%.
Operating Margin history for BioMarin Pharmaceutical from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -4.08% | 79.41% |
| 2020 | -2.27% | -59.11% |
| 2019 | -5.56% | -41.86% |
| 2018 | -9.57% | 250.42% |
| 2017 | -2.73% | -96.33% |
| 2016 | -74.41% | 327.97% |
| 2015 | -17.39% | 4.58% |
| 2014 | -16.63% | -48.33% |
| 2013 | -32.18% | 36.23% |
| 2012 | -23.62% | 138.97% |
| 2011 | -9.88% | 73.07% |
| 2010 | -5.71% | -3376.03% |
| 2009 | 0.17% | -98.45% |
| 2008 | 11.27% | -190.92% |
| 2007 | -12.40% | -57.68% |
| 2006 | -29.30% | -88.29% |
| 2005 | -250.16% | -68.47% |
| 2004 | -793.48% | 26.66% |
| 2003 | -626.47% | 28.95% |
| 2002 | -485.84% | 41.03% |
| 2001 | -344.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 19.90% | 298.00% | 🇫🇷 France |
 Ultragenyx RARE | -186.36% | -3,827.20% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -160.78% | -3,315.60% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -343.04% | -6,960.80% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -78.02% | -1,660.40% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 44.07% | 781.40% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.